APA (7th ed.) Citation

A, T., E, C., VN, G., E, P., M, B., CM, R., . . . MQ, S. (2025). Safety of Post-Transplant Cyclophosphamide-Based Prophylaxis in AML Patients with Pre-Existing Cardiac Morbidity Undergoing Allogeneic Hematopoietic Cell Transplantation. Cancers, 17(19), . https://doi.org/10.3390/cancers17193128

Chicago Style (17th ed.) Citation

A, Torrent-Rodríguez, et al. "Safety of Post-Transplant Cyclophosphamide-Based Prophylaxis in AML Patients with Pre-Existing Cardiac Morbidity Undergoing Allogeneic Hematopoietic Cell Transplantation." Cancers 17, no. 19 (2025). https://doi.org/10.3390/cancers17193128.

MLA (9th ed.) Citation

A, Torrent-Rodríguez, et al. "Safety of Post-Transplant Cyclophosphamide-Based Prophylaxis in AML Patients with Pre-Existing Cardiac Morbidity Undergoing Allogeneic Hematopoietic Cell Transplantation." Cancers, vol. 17, no. 19, 2025, https://doi.org/10.3390/cancers17193128.